IDO1 and cancer: Particularly, CAFs may inhibit NK cell-mediated killing of cancer cells, via expression of soluble mediators such as indoleamine-pyrrole 2,3-dioxygenase (IDO), matrix metalloproteinases, or prostaglandin E2 (PGE2) (32–34).